Clinical Significance of Heme Oxygenase 1 in Tumor Progression
- PMID: 34067625
- PMCID: PMC8155918
- DOI: 10.3390/antiox10050789
Clinical Significance of Heme Oxygenase 1 in Tumor Progression
Abstract
Heme oxygenase 1 (HO-1) plays a key role in cell adaptation to stressors through the antioxidant, antiapoptotic, and anti-inflammatory properties of its metabolic products. For these reasons, in cancer cells, HO-1 can favor aggressiveness and resistance to therapies, leading to poor prognosis/outcome. Genetic polymorphisms of HO-1 promoter have been associated with an increased risk of cancer progression and a high degree of therapy failure. Moreover, evidence from cancer biopsies highlights the possible correlation between HO-1 expression, pathological features, and clinical outcome. Indeed, high levels of HO-1 in tumor specimens often correlate with reduced survival rates. Furthermore, HO-1 modulation has been proposed in order to improve the efficacy of antitumor therapies. However, contrasting evidence on the role of HO-1 in tumor biology has been reported. This review focuses on the role of HO-1 as a promising biomarker of cancer progression; understanding the correlation between HO-1 and clinical data might guide the therapeutic choice and improve the outcome of patients in terms of prognosis and life quality.
Keywords: HO-1; Nrf2; biomarker; cancer progression; patients; prognosis; therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Pharmacological Significance of Heme Oxygenase 1 in Prostate Cancer.Curr Issues Mol Biol. 2023 May 15;45(5):4301-4316. doi: 10.3390/cimb45050273. Curr Issues Mol Biol. 2023. PMID: 37232742 Free PMC article. Review.
-
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition.Int J Cancer. 2020 Apr 1;146(7):1950-1962. doi: 10.1002/ijc.32611. Epub 2019 Aug 24. Int J Cancer. 2020. PMID: 31376303
-
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation.Antioxidants (Basel). 2017 May 5;6(2):29. doi: 10.3390/antiox6020029. Antioxidants (Basel). 2017. PMID: 28475131 Free PMC article. Review.
-
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance.Oxid Med Cell Longev. 2016;2016:1958174. doi: 10.1155/2016/1958174. Epub 2015 Nov 30. Oxid Med Cell Longev. 2016. PMID: 26697129 Free PMC article. Review.
-
The role of heme oxygenase-1 in pulmonary disease.Am J Respir Cell Mol Biol. 2007 Feb;36(2):158-65. doi: 10.1165/rcmb.2006-0331TR. Epub 2006 Sep 15. Am J Respir Cell Mol Biol. 2007. PMID: 16980551 Free PMC article. Review.
Cited by
-
Novel Acetamide-Based HO-1 Inhibitor Counteracts Glioblastoma Progression by Interfering with the Hypoxic-Angiogenic Pathway.Int J Mol Sci. 2024 May 15;25(10):5389. doi: 10.3390/ijms25105389. Int J Mol Sci. 2024. PMID: 38791428 Free PMC article.
-
The Pharmacological Effect of Hemin in Inflammatory-Related Diseases: A Systematic Review.Biomedicines. 2024 Apr 18;12(4):898. doi: 10.3390/biomedicines12040898. Biomedicines. 2024. PMID: 38672251 Free PMC article. Review.
-
Flavonoids with Anti-Angiogenesis Function in Cancer.Molecules. 2024 Mar 31;29(7):1570. doi: 10.3390/molecules29071570. Molecules. 2024. PMID: 38611849 Free PMC article. Review.
-
Pathological significance of heme oxygenase-1 as a potential tumor promoter in heme-induced colorectal carcinogenesis.Cancer Pathog Ther. 2023 Apr 13;2(2):65-73. doi: 10.1016/j.cpt.2023.04.001. eCollection 2024 Apr. Cancer Pathog Ther. 2023. PMID: 38601482 Free PMC article. Review.
-
Article review: Brazilin as potential anticancer agent.Front Pharmacol. 2024 Mar 7;15:1355533. doi: 10.3389/fphar.2024.1355533. eCollection 2024. Front Pharmacol. 2024. PMID: 38515856 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources